nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CYP2D6—Hydroxyurea—head and neck cancer	0.301	0.567	CbGbCtD
Tiotropium—CYP2D6—Vinblastine—head and neck cancer	0.107	0.201	CbGbCtD
Tiotropium—SLC22A4—glottis—head and neck cancer	0.0725	0.413	CbGeAlD
Tiotropium—CYP3A4—Vinblastine—head and neck cancer	0.0678	0.128	CbGbCtD
Tiotropium—CYP3A4—Docetaxel—head and neck cancer	0.0559	0.105	CbGbCtD
Tiotropium—SLC22A4—larynx—head and neck cancer	0.0256	0.146	CbGeAlD
Tiotropium—Ileus paralytic—Vinblastine—head and neck cancer	0.0182	0.0619	CcSEcCtD
Tiotropium—Skin ulcer—Hydroxyurea—head and neck cancer	0.00921	0.0314	CcSEcCtD
Tiotropium—CHRM3—exocrine gland—head and neck cancer	0.0084	0.0479	CbGeAlD
Tiotropium—Bone pain—Vinblastine—head and neck cancer	0.0082	0.0279	CcSEcCtD
Tiotropium—SLC22A4—neck—head and neck cancer	0.0068	0.0388	CbGeAlD
Tiotropium—CHRM5—epithelium—head and neck cancer	0.00653	0.0373	CbGeAlD
Tiotropium—Oral candidiasis—Docetaxel—head and neck cancer	0.00586	0.02	CcSEcCtD
Tiotropium—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00568	0.0194	CcSEcCtD
Tiotropium—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00552	0.0188	CcSEcCtD
Tiotropium—Intestinal obstruction—Docetaxel—head and neck cancer	0.00546	0.0186	CcSEcCtD
Tiotropium—Laryngeal pain—Docetaxel—head and neck cancer	0.00546	0.0186	CcSEcCtD
Tiotropium—CHRM1—parotid gland—head and neck cancer	0.00489	0.0279	CbGeAlD
Tiotropium—Angina pectoris—Vinblastine—head and neck cancer	0.0048	0.0164	CcSEcCtD
Tiotropium—CHRM1—saliva-secreting gland—head and neck cancer	0.00468	0.0267	CbGeAlD
Tiotropium—Dysuria—Hydroxyurea—head and neck cancer	0.0042	0.0143	CcSEcCtD
Tiotropium—CHRM3—saliva-secreting gland—head and neck cancer	0.00419	0.0239	CbGeAlD
Tiotropium—SLC22A4—trachea—head and neck cancer	0.00409	0.0233	CbGeAlD
Tiotropium—CHRM5—head—head and neck cancer	0.00405	0.0231	CbGeAlD
Tiotropium—Pharyngitis—Vinblastine—head and neck cancer	0.00392	0.0133	CcSEcCtD
Tiotropium—Stomatitis—Hydroxyurea—head and neck cancer	0.00391	0.0133	CcSEcCtD
Tiotropium—Bone pain—Docetaxel—head and neck cancer	0.00389	0.0132	CcSEcCtD
Tiotropium—SLC22A5—parotid gland—head and neck cancer	0.00366	0.0209	CbGeAlD
Tiotropium—Influenza like illness—Docetaxel—head and neck cancer	0.00362	0.0123	CcSEcCtD
Tiotropium—CHRM1—trachea—head and neck cancer	0.00361	0.0206	CbGeAlD
Tiotropium—Candida infection—Docetaxel—head and neck cancer	0.00355	0.0121	CcSEcCtD
Tiotropium—SLC22A5—saliva-secreting gland—head and neck cancer	0.00351	0.02	CbGeAlD
Tiotropium—Dry skin—Fluorouracil—head and neck cancer	0.00343	0.0117	CcSEcCtD
Tiotropium—Angiopathy—Hydroxyurea—head and neck cancer	0.00327	0.0111	CcSEcCtD
Tiotropium—Dysphagia—Fluorouracil—head and neck cancer	0.00324	0.011	CcSEcCtD
Tiotropium—SLC22A4—thyroid gland—head and neck cancer	0.00324	0.0185	CbGeAlD
Tiotropium—Angina pectoris—Fluorouracil—head and neck cancer	0.00315	0.0107	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00301	0.0102	CcSEcCtD
Tiotropium—Hypertension—Vinblastine—head and neck cancer	0.00297	0.0101	CcSEcCtD
Tiotropium—Stomatitis—Fluorouracil—head and neck cancer	0.00281	0.00958	CcSEcCtD
Tiotropium—Urinary tract infection—Fluorouracil—head and neck cancer	0.0028	0.00955	CcSEcCtD
Tiotropium—CHRM2—head—head and neck cancer	0.00278	0.0159	CbGeAlD
Tiotropium—Epistaxis—Fluorouracil—head and neck cancer	0.00272	0.00927	CcSEcCtD
Tiotropium—Sinusitis—Fluorouracil—head and neck cancer	0.00271	0.00922	CcSEcCtD
Tiotropium—SLC22A5—trachea—head and neck cancer	0.00271	0.0154	CbGeAlD
Tiotropium—Pain in extremity—Docetaxel—head and neck cancer	0.0027	0.00921	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00265	0.00902	CcSEcCtD
Tiotropium—Rhinitis—Fluorouracil—head and neck cancer	0.0026	0.00885	CcSEcCtD
Tiotropium—Pharyngitis—Fluorouracil—head and neck cancer	0.00257	0.00876	CcSEcCtD
Tiotropium—Oedema—Hydroxyurea—head and neck cancer	0.00256	0.00871	CcSEcCtD
Tiotropium—CHRM3—thyroid gland—head and neck cancer	0.00256	0.0146	CbGeAlD
Tiotropium—Infection—Hydroxyurea—head and neck cancer	0.00254	0.00865	CcSEcCtD
Tiotropium—CHRM1—head—head and neck cancer	0.00253	0.0144	CbGeAlD
Tiotropium—Paraesthesia—Vinblastine—head and neck cancer	0.00252	0.00858	CcSEcCtD
Tiotropium—Dehydration—Docetaxel—head and neck cancer	0.00251	0.00856	CcSEcCtD
Tiotropium—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00251	0.00854	CcSEcCtD
Tiotropium—Skin disorder—Hydroxyurea—head and neck cancer	0.00248	0.00846	CcSEcCtD
Tiotropium—Dry skin—Docetaxel—head and neck cancer	0.00248	0.00844	CcSEcCtD
Tiotropium—Constipation—Vinblastine—head and neck cancer	0.0024	0.00817	CcSEcCtD
Tiotropium—Dysphagia—Docetaxel—head and neck cancer	0.00234	0.00796	CcSEcCtD
Tiotropium—Arrhythmia—Fluorouracil—head and neck cancer	0.00231	0.00788	CcSEcCtD
Tiotropium—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00229	0.00781	CcSEcCtD
Tiotropium—Angina pectoris—Docetaxel—head and neck cancer	0.00228	0.00775	CcSEcCtD
Tiotropium—CHRM3—head—head and neck cancer	0.00227	0.0129	CbGeAlD
Tiotropium—Dyspepsia—Hydroxyurea—head and neck cancer	0.00225	0.00767	CcSEcCtD
Tiotropium—Abdominal pain—Vinblastine—head and neck cancer	0.00222	0.00755	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00221	0.00752	CcSEcCtD
Tiotropium—Constipation—Hydroxyurea—head and neck cancer	0.00219	0.00745	CcSEcCtD
Tiotropium—SLC22A5—thyroid gland—head and neck cancer	0.00214	0.0122	CbGeAlD
Tiotropium—Vision blurred—Fluorouracil—head and neck cancer	0.00213	0.00724	CcSEcCtD
Tiotropium—Hypersensitivity—Vinblastine—head and neck cancer	0.00207	0.00704	CcSEcCtD
Tiotropium—Renal failure—Docetaxel—head and neck cancer	0.00205	0.00697	CcSEcCtD
Tiotropium—Stomatitis—Docetaxel—head and neck cancer	0.00203	0.00692	CcSEcCtD
Tiotropium—SLC22A4—lymph node—head and neck cancer	0.00201	0.0115	CbGeAlD
Tiotropium—Epistaxis—Docetaxel—head and neck cancer	0.00196	0.00669	CcSEcCtD
Tiotropium—Chest pain—Fluorouracil—head and neck cancer	0.00192	0.00654	CcSEcCtD
Tiotropium—Myalgia—Fluorouracil—head and neck cancer	0.00192	0.00654	CcSEcCtD
Tiotropium—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00188	0.00642	CcSEcCtD
Tiotropium—Rhinitis—Docetaxel—head and neck cancer	0.00187	0.00638	CcSEcCtD
Tiotropium—Pharyngitis—Docetaxel—head and neck cancer	0.00186	0.00632	CcSEcCtD
Tiotropium—Dizziness—Vinblastine—head and neck cancer	0.00185	0.00632	CcSEcCtD
Tiotropium—Urinary tract disorder—Docetaxel—head and neck cancer	0.00185	0.00629	CcSEcCtD
Tiotropium—Oedema peripheral—Docetaxel—head and neck cancer	0.00184	0.00627	CcSEcCtD
Tiotropium—Oedema—Fluorouracil—head and neck cancer	0.00184	0.00627	CcSEcCtD
Tiotropium—Connective tissue disorder—Docetaxel—head and neck cancer	0.00184	0.00626	CcSEcCtD
Tiotropium—Urethral disorder—Docetaxel—head and neck cancer	0.00183	0.00624	CcSEcCtD
Tiotropium—Infection—Fluorouracil—head and neck cancer	0.00183	0.00623	CcSEcCtD
Tiotropium—Nervous system disorder—Fluorouracil—head and neck cancer	0.0018	0.00615	CcSEcCtD
Tiotropium—Visual impairment—Docetaxel—head and neck cancer	0.0018	0.00614	CcSEcCtD
Tiotropium—Tachycardia—Fluorouracil—head and neck cancer	0.0018	0.00612	CcSEcCtD
Tiotropium—Vomiting—Vinblastine—head and neck cancer	0.00178	0.00607	CcSEcCtD
Tiotropium—Headache—Vinblastine—head and neck cancer	0.00176	0.00598	CcSEcCtD
Tiotropium—Eye disorder—Docetaxel—head and neck cancer	0.00175	0.00595	CcSEcCtD
Tiotropium—Angiopathy—Docetaxel—head and neck cancer	0.0017	0.00578	CcSEcCtD
Tiotropium—Dizziness—Hydroxyurea—head and neck cancer	0.00169	0.00576	CcSEcCtD
Tiotropium—Immune system disorder—Docetaxel—head and neck cancer	0.00169	0.00575	CcSEcCtD
Tiotropium—Mediastinal disorder—Docetaxel—head and neck cancer	0.00169	0.00574	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00168	0.00571	CcSEcCtD
Tiotropium—Arrhythmia—Docetaxel—head and neck cancer	0.00167	0.00569	CcSEcCtD
Tiotropium—Nausea—Vinblastine—head and neck cancer	0.00167	0.00567	CcSEcCtD
Tiotropium—Insomnia—Fluorouracil—head and neck cancer	0.00166	0.00567	CcSEcCtD
Tiotropium—Paraesthesia—Fluorouracil—head and neck cancer	0.00165	0.00563	CcSEcCtD
Tiotropium—Mental disorder—Docetaxel—head and neck cancer	0.00164	0.00558	CcSEcCtD
Tiotropium—Malnutrition—Docetaxel—head and neck cancer	0.00163	0.00554	CcSEcCtD
Tiotropium—Vomiting—Hydroxyurea—head and neck cancer	0.00163	0.00554	CcSEcCtD
Tiotropium—Dyspepsia—Fluorouracil—head and neck cancer	0.00162	0.00552	CcSEcCtD
Tiotropium—Rash—Hydroxyurea—head and neck cancer	0.00161	0.00549	CcSEcCtD
Tiotropium—Dermatitis—Hydroxyurea—head and neck cancer	0.00161	0.00549	CcSEcCtD
Tiotropium—Headache—Hydroxyurea—head and neck cancer	0.0016	0.00546	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00159	0.00541	CcSEcCtD
Tiotropium—Back pain—Docetaxel—head and neck cancer	0.00157	0.00536	CcSEcCtD
Tiotropium—Nausea—Hydroxyurea—head and neck cancer	0.00152	0.00517	CcSEcCtD
Tiotropium—Urticaria—Fluorouracil—head and neck cancer	0.00146	0.00498	CcSEcCtD
Tiotropium—Syncope—Docetaxel—head and neck cancer	0.00146	0.00497	CcSEcCtD
Tiotropium—Palpitations—Docetaxel—head and neck cancer	0.00144	0.0049	CcSEcCtD
Tiotropium—Loss of consciousness—Docetaxel—head and neck cancer	0.00143	0.00487	CcSEcCtD
Tiotropium—Cough—Docetaxel—head and neck cancer	0.00142	0.00484	CcSEcCtD
Tiotropium—Hypertension—Docetaxel—head and neck cancer	0.00141	0.00479	CcSEcCtD
Tiotropium—Arthralgia—Docetaxel—head and neck cancer	0.00139	0.00472	CcSEcCtD
Tiotropium—Chest pain—Docetaxel—head and neck cancer	0.00139	0.00472	CcSEcCtD
Tiotropium—Myalgia—Docetaxel—head and neck cancer	0.00139	0.00472	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00138	0.00469	CcSEcCtD
Tiotropium—Hypersensitivity—Fluorouracil—head and neck cancer	0.00136	0.00462	CcSEcCtD
Tiotropium—Dry mouth—Docetaxel—head and neck cancer	0.00136	0.00462	CcSEcCtD
Tiotropium—SLC22A5—lymph node—head and neck cancer	0.00133	0.00759	CbGeAlD
Tiotropium—Oedema—Docetaxel—head and neck cancer	0.00133	0.00452	CcSEcCtD
Tiotropium—Infection—Docetaxel—head and neck cancer	0.00132	0.00449	CcSEcCtD
Tiotropium—Shock—Docetaxel—head and neck cancer	0.00131	0.00445	CcSEcCtD
Tiotropium—Nervous system disorder—Docetaxel—head and neck cancer	0.0013	0.00444	CcSEcCtD
Tiotropium—Pruritus—Fluorouracil—head and neck cancer	0.0013	0.00444	CcSEcCtD
Tiotropium—Tachycardia—Docetaxel—head and neck cancer	0.0013	0.00442	CcSEcCtD
Tiotropium—Skin disorder—Docetaxel—head and neck cancer	0.00129	0.00439	CcSEcCtD
Tiotropium—CYP2D6—head—head and neck cancer	0.00123	0.00699	CbGeAlD
Tiotropium—Dizziness—Fluorouracil—head and neck cancer	0.00122	0.00415	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00121	0.00412	CcSEcCtD
Tiotropium—Insomnia—Docetaxel—head and neck cancer	0.0012	0.00409	CcSEcCtD
Tiotropium—Paraesthesia—Docetaxel—head and neck cancer	0.00119	0.00406	CcSEcCtD
Tiotropium—Vomiting—Fluorouracil—head and neck cancer	0.00117	0.00399	CcSEcCtD
Tiotropium—Dyspepsia—Docetaxel—head and neck cancer	0.00117	0.00398	CcSEcCtD
Tiotropium—Rash—Fluorouracil—head and neck cancer	0.00116	0.00395	CcSEcCtD
Tiotropium—Dermatitis—Fluorouracil—head and neck cancer	0.00116	0.00395	CcSEcCtD
Tiotropium—Headache—Fluorouracil—head and neck cancer	0.00115	0.00393	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00115	0.00391	CcSEcCtD
Tiotropium—Constipation—Docetaxel—head and neck cancer	0.00114	0.00387	CcSEcCtD
Tiotropium—Nausea—Fluorouracil—head and neck cancer	0.00109	0.00372	CcSEcCtD
Tiotropium—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00109	0.0037	CcSEcCtD
Tiotropium—Abdominal pain—Docetaxel—head and neck cancer	0.00105	0.00358	CcSEcCtD
Tiotropium—Hypersensitivity—Docetaxel—head and neck cancer	0.000979	0.00333	CcSEcCtD
Tiotropium—Pruritus—Docetaxel—head and neck cancer	0.00094	0.0032	CcSEcCtD
Tiotropium—Dizziness—Docetaxel—head and neck cancer	0.000878	0.00299	CcSEcCtD
Tiotropium—Vomiting—Docetaxel—head and neck cancer	0.000845	0.00288	CcSEcCtD
Tiotropium—Rash—Docetaxel—head and neck cancer	0.000838	0.00285	CcSEcCtD
Tiotropium—Dermatitis—Docetaxel—head and neck cancer	0.000837	0.00285	CcSEcCtD
Tiotropium—Headache—Docetaxel—head and neck cancer	0.000832	0.00283	CcSEcCtD
Tiotropium—Nausea—Docetaxel—head and neck cancer	0.000789	0.00269	CcSEcCtD
